Patent · US Active

Quinazoline compounds, preparation method, use, and pharmaceutical composition thereof

US11534443B2 · kind B2 · utility

0Cited by

0References

13Claims

0Family size

Assignee

INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES · CN

Inventors

Heng Xu · Alameda, US
Xiaoguang Chen · Beijing, CN
Songwen LIN · Beijing, CN
Ming Ji · Beijing, CN
Jing Jin · Beijing, CN
Deyu WU · Beijing, CN
Chunyang Wang · Hefei, CN
Yuanhao LV · Beijing, CN

Key dates

Filing date	Dec 26, 2017
Grant date	Dec 27, 2022
Priority date	—
Expiry date	Feb 22, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to quinazoline compounds, the preparation method, use, and the pharmaceutical composition thereof. The said quinazoline compounds, which are represented by Formula (I), are phosphatidylinositol 3-kinase (PI3K) inhibitors, and can be applied to prevent and/or treat PI3K activity-related diseases, such as cancer, immune diseases, cardiovascular diseases, viral infections, inflammation, metabolism/endocrine function disorders or neurological diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.